doi:10.1039/D1FO03352B Henderson AM, Aleliunas RE, Loh SP, et al
MT2 has the potential to induce nausea, although I personally never noticed this downside
At the end of the study, the women who received the GLP-1 agonist had lost an average of 4.9 kg (10.8 lbs) and had significant improvements in insulin resistance, fasting glucose, and cholesterol levels
Anyone continuing to sell mass compounded tirzepatide is breaking the law and deceiving patients. They went on to say in an emailed statement, Lilly has filed lawsuits alleging entities are deceptively marketing knockoff tirzepatide as safe and effective for cosmetic weight loss, improperly practicing medicine or influencing medical decisions, falsely claiming to sell personalized compounded tirzepatide, and misleading consumers about the safety, clinical testing, and effectiveness of their risky, unapproved knockoffs